Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 335 other Healthcare companies of similar size
Ranked #88 of 336 · scores higher than 74% of peers · safety percentile 75
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)40 peers with a safety percentile of 70–79, including AXGN · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 323 reported | 0.08× | 0.24× | 71% | 33% | |
| BetaLower is better · 321 reported | 1.17 | 0.56 | 19% | 33% | |
| Current ratioHigher is better · 323 reported | 6.60× | 2.88× | 79% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 84 | 28.4B CNY (≈$4.0B) | 77 | 62 | |
| 85 | 18.9B CNY (≈$2.6B) | 77 | 49 | |
| 86 | 158.6B INR (≈$1.9B) | 76 | 70 | |
| 87 | 3.3B USD | 76 | 39 | |
| 88 | 2.9B USD | 75 | 44 | |
| 89 | 179.7B INR (≈$2.2B) | 75 | 74 | |
| 90 | 254.3B JPY (≈$1.7B) | 74 | 61 | |
| 91 | 263.1B JPY (≈$1.8B) | 74 | 72 | |
| 92 | 13.3B CNY (≈$1.9B) | 73 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score